{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreie562kdgbl2eapk2w2bm7kx6fig4vhvcd4eeaetyk7bk6kb4slabi",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mlfgfyvl5ht2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibsca423mqf5awo3q3kuewkerzuuscsliscxlq4fw6s2nwweyn5qm"
    },
    "mimeType": "image/jpeg",
    "size": 59402
  },
  "path": "/2026/05/08/supreme-court-mifepristone-amicus-briefs-pharma-former-fda-leaders/?utm_campaign=rss",
  "publishedAt": "2026-05-08T15:23:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Health",
    "Politics",
    "abortion",
    "Congress",
    "FDA",
    "legal",
    "Pharmaceuticals",
    "reproductive health",
    "states",
    "Supreme Court"
  ],
  "textContent": "“The fundamental question is: Who gets to regulate mifepristone?”",
  "title": "Former FDA leaders, pharma speak out on mifepristone",
  "updatedAt": "2026-05-08T17:17:54.000Z"
}